Takeda

Second quarter

Pharma

Of biopharma's top 25 companies, 9 had double-digit sales bumps

Biopharma sales boomed in Q2. Of the top 25 revenue companies, nine had YoY double-digit increases and 13 saw sequential increases of at least 10%.

Kevin Dunleavy Aug 12, 2026 11:47am

Asia

Takeda, Daiichi, Astellas and more—Fierce Pharma Asia

Aug 7, 2026 8:35am

Takeda

FDA approves Takeda's first-in-class Orzeyful for narcolepsy

Aug 6, 2026 11:10am

Asia

Legend Biotech, Merck, Otsuka—Fierce Pharma Asia

Jul 31, 2026 9:00am

Asia

Generic tariffs, Samsung Bio, HK IPO—Fierce Pharma Asia

Jul 24, 2026 9:00am

Asia

AZ's China deals, Kailera-Hengrui—Fierce Pharma Asia

Jul 10, 2026 8:51am